Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Intra-Cellular Therapies Inc. | 23 | 0 | 6 | 0 | €64.50 | €79.43 | 23.147% |
TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.05 | €28.06 | 86.426% |
Heron Therapeutics Inc. | 9 | 1 | 4 | 0 | €2.42 | €4.57 | 89.000% |
Twist Bioscience Corp | 7 | 0 | 4 | 0 | €39.72 | €41.41 | 4.252% |
Geron Corp. | 12 | 0 | 4 | 0 | €3.72 | €4.63 | 24.249% |
Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.60 | €35.43 | 56.767% |
Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
XOMA Corp. | 6 | 0 | 3 | 0 | €22.80 | €68.78 | 201.664% |
X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 158.705% |
Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €71.32 | €100.00 | 40.213% |
MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
Krystal Biotech | 16 | 0 | 3 | 0 | €151.00 | €173.22 | 14.714% |
G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.60 | €46.24 | 87.967% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.45 | €8.50 | 0.651% |
Evolus Inc | 7 | 0 | 2 | 0 | €12.30 | €20.26 | 64.678% |
Insmed Inc. | 13 | 1 | 2 | 1 | €23.60 | €44.01 | 86.469% |
Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €40.60 | €46.19 | 13.756% |
Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.75 | - | - |
Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €2.00 | €8.39 | 319.940% |
Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.78 | €8.27 | 118.625% |
Adaptimmune Therapeutics PLC ADR | 2 | 0 | 2 | 0 | €1.12 | €1.70 | 51.786% |
Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
Amneal Pharmaceuticals Inc | 1 | 1 | 1 | 0 | €6.30 | €10.00 | 58.730% |
Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €23.20 | €24.97 | 7.643% |